In a preclinical cerebellopontine schwannoma mouse model, treatment with an angiotensin‐receptor blocker (losartan) as an anti‐fibrotic through inhibition of IL‐6/STAT3 and TGF‐β, reduced the amount of collagen I and prevented tumor‐induced hearing loss.22 Here, IL6 is linked to neoplasm.